Similar articles

• Reducing chemotherapy-associated toxicity in elderly cancer patients.

  Zagonel V, Fratino L, Sacco C, Babare R, Spazzapan S, Gattei V, Improta S, Pinto A. Zagonel V, et al. Cancer Treat Rev. 1996 May;22(3):223-44. doi: 10.1016/s0305-7372(96)90003-1. Cancer Treat Rev. 1996. PMID: 8841391 Review. No abstract available.
• Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail?

  Demetri GD, Griffin JD. Demetri GD, et al. J Clin Oncol. 1990 May;8(5):761-4. doi: 10.1200/JCO.1990.8.5.761. J Clin Oncol. 1990. PMID: 1692086 No abstract available.
• [Medical complications of chemotherapy].

  Klastersky J. Klastersky J. Acta Clin Belg. 1975;30(6):538-46. doi: 10.1080/17843286.1975.11717049. Acta Clin Belg. 1975. PMID: 769462 Review. French. No abstract available.
• [Cardiotoxicity of antineoplastic drugs].

  Drzewoski J, Kasznicki J. Drzewoski J, et al. Acta Haematol Pol. 1992;23(2):79-86. Acta Haematol Pol. 1992. PMID: 1488864 Review. Polish.
• [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].

  Yamashita J, Kawamura T, Shoin K. Yamashita J, et al. No Shinkei Geka. 1990 Apr;18(4):329-38. No Shinkei Geka. 1990. PMID: 2197571 Review. Japanese. No abstract available.